Acadia Pharmaceuticals Inc.
A$29.72
AUD
Last updated on --.
24h volume706.63K
24h highest30.1400 AUD
24h lowest29.0652 AUD
24h Price movement+0.78%
ACAD recent prices
24 Hours
+0.78%+A$0.23062
30 days
-4.64%-A$1.447
60 days
+1.64%+A$0.47522
90 days
-13.70%-A$4.718
Key data
Previous close29.4915 AUD
Market cap5.01B AUD
Volume706.63K
P/E ratio9.550000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)3.0610 AUD
Net income (FY)525.05M AUD
Revenue (FY)1.53B AUD
Last report date7 May 2026
About Acadia Pharmaceuticals Inc.
HeadquartersSAN DIEGO
Employees (FY)798.00
Revenue per employee (FY)1.92M AUD
Net income per employee (FY)657.95K AUD
Listed onNasdaq
ACAD conversion tables
 |  |
|---|---|
| 0.5 ACAD | 14.86 AUD |
| 1 ACAD | 29.72 AUD |
| 5 ACAD | 148.61 AUD |
| 10 ACAD | 297.22 AUD |
| |
|---|---|
| 0.5 AUD | 0.016823 ACAD |
| 1 AUD | 0.033645 ACAD |
| 5 AUD | 0.16823 ACAD |
| 10 AUD | 0.33645 ACAD |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ACAD is trading at A$29.72, +0.78% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ACAD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ACAD is currently trading at A$29.72, +0.78% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ACAD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ACAD's P/E ratio is currently 9.550000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ACAD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ACAD's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Acadia Pharmaceuticals Inc.'s market cap is currently 5.01B AUD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume706.63K
24h highest30.1400 AUD
24h lowest29.0652 AUD
24h Price movement+0.78%
Start trade with ACAD Perpetual
Sign up to trade